Feb 03, 2016 12:30 pm UTC| Business
SAN DIEGO, Feb. 03, 2016 -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections, today announced it will be...
FirstService Completes Four Acquisitions
Feb 03, 2016 12:30 pm UTC| Business
TORONTO, Feb. 03, 2016 -- FirstService Corporation (NASDAQ:FSV) (TSX:FSV) announced today that it has expanded its market-leading residential property management operations with the acquisitions of K.A. Diehl in South...
Feb 03, 2016 12:24 pm UTC| Business
Deerfield Beach, FL, Feb. 03, 2016 -- Zion Research has released a new report titled “Acetaminophen (Paracetamol) Market for Pharmaceuticals, Dye Industry and Chemical Industry - Global Industry Perspective,...
KESSLER FOUNDATION RECEIVES $1 M GRANT TO STUDY BENEFITS OF EKSO BIONICS' EKSO GT(TM) EXOSKELETON
Feb 03, 2016 12:17 pm UTC| Business
WEST ORANGE, N.J., Feb. 3, 2016 -- Kessler Foundation, a global leader in rehabilitation research, announced today that it will use the Ekso GT™ of Ekso Bionics (OTCQB:EKSO) in a multi-center randomized controlled...
Mended Little Hearts Rock Your Scar Photo Contest
Feb 03, 2016 12:13 pm UTC| Business
DALLAS, Feb. 3, 2016 -- Heart surgery is tough, especially if you are a kid. The resulting physical and emotional scars often leave kids—and adults—feeling embarrassed or ashamed. But Mended LittleHearts...
Sage Therapeutics to Present at the 2016 Leerink Global Healthcare Conference
Feb 03, 2016 12:00 pm UTC| Business
CAMBRIDGE, Mass., Feb. 03, 2016 -- SAGE Therapeutics(NASDAQ:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system disorders, today announced thatJeff...
Heat Biologics Reports Update on Its HS-410 Phase 2 Bladder Cancer Trial
Feb 03, 2016 12:00 pm UTC| Business
The company anticipates clinical timelines for HS-410 to remain materially unchanged DURHAM, N.C., Feb. 03, 2016 -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), an immuno-oncology company developing novel therapies...